Upper Airway Cough Syndrome Medical Services in China
Through ChinaMedicalHub medical tourism agency, learn about Upper Airway Cough Syndrome medical services, process and cost in China. We provide fast-track appointments, visa assistance, medical interpreters, airport transfers and personal escort services.
ChinaMedicalHub is a medical tourism coordination service. We connect international patients with partner hospitals in China and provide consultation, appointment booking, visa assistance, interpretation and escort services. Content on this website is for reference only and does not constitute medical advice. Please consult qualified healthcare professionals for specific treatment plans.
Disease Overview
Upper Airway Cough Syndrome (UACS), formerly known as postnasal drip syndrome, is a common chronic cough etiology characterized by persistent cough lasting more than eight weeks, primarily driven by rhinosinus pathology—including allergic or non-allergic rhinitis, chronic sinusitis, or nasal polyposis. Symptoms include throat clearing, sensation of mucus dripping into the pharynx, nasal congestion, and often concomitant laryngeal irritation. Diagnosis relies on clinical evaluation, nasolaryngoscopy, and sometimes sinonasal imaging (e.g., CT of paranasal sinuses) to exclude structural abnormalities or comorbid conditions like asthma or gastroesophageal reflux disease. Management is multimodal: intranasal corticosteroids, second-generation antihistamines, saline irrigation, and, when indicated, targeted endoscopic sinus surgery (ESS) for refractory cases.
China offers distinct advantages in UACS management: leading respiratory centers—such as Peking Union Medical College Hospital and Shanghai Ruijin Hospital—boast internationally trained otolaryngologists and pulmonologists with extensive experience in complex airway disorders. Advanced diagnostic tools—including high-resolution nasal endoscopy, acoustic rhinometry, and 3D-guided ESS platforms—are widely deployed. Clinical outcomes align with global benchmarks: over 90% of medically managed patients report significant symptom reduction within 4–6 weeks; surgical success rates for chronic sinusitis-related UACS exceed 85% at top-tier institutions. Treatment costs in China are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based protocols or safety standards.
As a dedicated medical tourism agency, we facilitate seamless care for international patients: verifying physician credentials, coordinating appointments across multidisciplinary teams, providing itemized, transparent pricing in advance, and offering end-to-end support—from visa assistance and accommodation to post-discharge follow-up coordination.
Upper Airway Cough Syndrome: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Our Services for International Patients
Why Consider China for Medical Services
China offers a compelling option for patients seeking treatment for Upper Airway Cough Syndrome (UACS), formerly known as postnasal drip syndrome. Treatment costs in China are typically 40–60% lower than in the U.S. or Western Europe—for example, comprehensive diagnostic workups including nasal endoscopy, allergy testing, and pulmonary function assessment may cost under $800, compared to $2,500–$4,000 elsewhere. Chinese respiratory centers utilize advanced equipment such as high-resolution rhinolaryngoscopes, fractional CO₂ lasers for turbinate reduction, and validated symptom scoring tools aligned with international guidelines. Many hospitals have over two decades of clinical experience managing chronic cough subtypes, with multidisciplinary teams integrating ENT, allergy, and respiratory specialists. Our agency supports patients with transparent, itemized pricing, pre-travel budget planning, and evidence-based hospital selection—prioritizing institutions accredited by China’s National Health Commission and experienced in UACS management. The treatment process is streamlined: initial virtual consultations, coordinated in-person evaluations within 48 hours of arrival, and follow-up via secure telemedicine. Language support, medical record translation, and logistical assistance—including visa guidance and accommodation—are included to minimize administrative burden.
Medical Care Journey for International Patients
International Patient Treatment Process for Upper Airway Cough Syndrome (UACS): After initial online consultation with our respiratory medicine specialists, patients receive a personalized assessment and diagnostic plan. Our agency assists with scheduling all appointments—including ENT evaluation, nasal endoscopy, and pulmonary function testing—at partner hospitals in China. We provide certified medical translators for all consultations and procedures, and assign bilingual patient coordinators for in-person accompaniment throughout the visit. Accommodation near the hospital is arranged based on preference and budget, with options including serviced apartments or partner hotels. Required materials include recent medical records (in English or Chinese), imaging reports (CT/MRI of sinuses), pulmonary function tests, and ID/passport copies. The full process typically takes 7–10 days: Day 1–2 for intake assessment and diagnostics; Days 3–6 for specialist review, treatment initiation (e.g., intranasal corticosteroids, antihistamines, or saline irrigation), and symptom monitoring; Day 7–10 for follow-up and discharge planning. All international patients receive 24/7 multilingual support (English, Arabic, Russian, Spanish), visa assistance letters, medication translation, and post-return teleconsultation coordination. Treatment completion is confirmed when cough resolution is documented and a management plan is shared with the referring physician.
What to Expect When Coming to China
Medical Travel to China Guide: Upper Airway Cough Syndrome (UACS)
To visit China for UACS evaluation and treatment, most nationalities require a valid Chinese visa—typically an L (tourist) or M (business) visa. We assist with invitation letters from partner hospitals and guide you through streamlined visa application support. Medical insurance is not accepted by most Chinese public hospitals; however, we provide transparent, all-inclusive pricing upfront—including consultations, endoscopic assessment, allergy testing, and targeted therapy—and accept secure international payments (bank transfer, credit card, or digital wallet). Our team coordinates comfortable, centrally located accommodations near partner respiratory centers, with optional companion stays and airport transfers. Post-consultation, we offer structured follow-up care: remote symptom monitoring via our secure portal, virtual check-ins with your treating pulmonologist at 2, 4, and 8 weeks, medication adherence support, and seamless coordination for any necessary repeat imaging or lab work back home. All services are integrated into one personalized care plan—no hidden fees, no language barriers, and continuous support from pre-travel planning through recovery. Let us handle the logistics while you focus on healing.
Service Information
Service Cost
800-3000 USD
* Actual costs may vary by individual
Service Duration
2-8 weeks
* Duration varies by severity
Recommended Hospitals
Peking Union Medical College Hospital
Professional Medical Institution
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Professional Medical Institution
Zhongshan Hospital Fudan University
Professional Medical Institution
West China Hospital, Sichuan University
Professional Medical Institution
The above hospitals are for reference only. Please consult a medical advisor for details.
FAQ & Guides
Sources & References
- American College of Chest Physicians - Diagnosis and Management of Upper Airway Cough Syndrome (UACS) — Official clinical practice guideline from CHEST providing evidence-based recommendations for diagnosis, evaluation, and treatment of UACS (formerly postnasal drip syndrome), including diagnostic criteria and pharmacologic/nonpharmacologic management.
- National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases - Rhinitis and Sinusitis — NIH/NIAID overview of upper airway inflammatory conditions contributing to UACS, including allergic and nonallergic rhinitis, chronic sinusitis, and their role in chronic cough pathogenesis.
- Mayo Clinic - Postnasal Drip — Patient- and clinician-oriented resource explaining postnasal drip as a key mechanism of UACS, covering symptoms, common causes (e.g., allergies, infections, GERD), and practical management strategies.
- MedlinePlus - Chronic Cough — NIH-curated, peer-reviewed health information page that includes UACS as a leading cause of chronic cough, with differential diagnosis context, clinical features, and links to related conditions (e.g., allergic rhinitis, sinusitis).
- American Academy of Otolaryngology–Head and Neck Surgery - Rhinosinusitis Clinical Practice Guideline — Evidence-based guideline addressing acute and chronic rhinosinusitis—key contributors to UACS—with diagnostic algorithms, imaging considerations, and medical/surgical management relevant to cough-predominant presentations.
This site is a medical service platform; some page content is AI-assisted and for reference only, not medical advice. See full disclaimer